From: Do the omeprazole family compounds exert a protective effect against influenza-like illness?
Multivariable analysis | |||||||||
---|---|---|---|---|---|---|---|---|---|
Variables | Adjusted OR§ | 95% CI | p | Adjusted OR§ | 95% CI | p | Adjusted OR§ | 95% CI | p |
Level 1 | Level 2 | Level 3 | |||||||
Demographic features and lifestyle habits | |||||||||
Aged 65 yrs or more* | 1.94 | 0.24;15.6 | 0.53 | ||||||
Smoking** | 0.64 | 0.37;1.14 | 0.13 | ||||||
Drinking**# | 3.04 | 1.22;7.59 | 0.02 | 2.17 | 0.87;5.51 | 0.09 ^ | 2.10 | 0.87;4.94 | 0.10 |
Underlying pathologies | |||||||||
Cardiovascular diseases** | 0.34 | 0.14;0.83 | 0.02 | 0.56 | 0.22;1.39 | 0.21 | |||
Hypertension** | 1.26 | 0.68;2.35 | 0.47 | ||||||
Respiratory diseases** | 1.64 | 0.73;3.71 | 0.23 | ||||||
Diabetes** | 0.96 | 0.29;3.17 | 0.94 | ||||||
Cancer** | 1.08 | 0.15;7.93 | 0.94 | ||||||
Kidney diseases** | 0.61 | 0.14;2.71 | 0.51 | ||||||
Dyslipidaemia** | 0.17 | 0.07;0.42 | 0.0001 | 0.12 | 1.56 | 0.20 | |||
Gastric ulcer** | 0.20 | 0.07;0.54 | 0.002 | 1.18 | 0.31;4.57 | 0.82 | |||
Gastric diseases**° | 0.38 | 0.13;1.12 | 0.08 ^ | 1.18 | 0.30;4.57 | 0.81 | |||
Drugs taken | |||||||||
Fibrates** | 0.08 | 0.05;1.41 | 0.09 ^ | 0.03 | 0.01;0.50 | 0.02 | |||
Statins** | 0.28 | 0.07;1.15 | 0.08 ^ | 0.15 | 0.05;0.43 | <0.001 | |||
Antibiotics** | 1.75 | 0.53;5.79 | 0.36 | ||||||
Omeprazole family compounds** | 0.31 | 0.13;0.76 | 0.01 | 0.29 | 0.15;0.52 | <0.001 | |||
Vaccination status | |||||||||
Influenza vaccination** | 0.31 | 0.16;0.58 | <0.001 |